Gestational diabetes mellitus: current screening problems
https://doi.org/10.14341/DM12727
Abstract
Gestational diabetes mellitus (GDM) is characterized as hyperglycemia, first detected during pregnancy, yet not meeting the criteria for “manifest” diabetes mellitus. GDM is one of the most common gestational complications. This pathology is associated with many adverse pregnancy outcomes, both on the part of the mother and the fetus. The problem of identifying GDM has acquired particular relevance and significance for the healthcare system at the moment due to the steady increase in the prevalence of such risk factors of GDM as obesity and late pregnancy. The history of screening and diagnosis of GDM has undergone a number of significant changes in a short time. Currently, different clinical guidelines offer different approaches to GDM screening, thus, a unified approach to identifying this pathology has not yet been formulated and adopted. The purpose of this review was to discover the current clinical guidelines for the detection of GDM at 24–28 weeks of pregnancy, including historical context of their origin and development, to describe these approaches, as well as to critically evaluate them with a discussion of the main advantages and disadvantages of each of them.
About the Authors
N. I. Volkova
Rostov State Medical University
Russian Federation
Competing Interests:
Russian Federation
Natalya I. Volkova - MD, PhD, Professor; eLibrary SPIN: 3146-8337.
Rostov-on-Don
Competing Interests:
none
S. O. Panenko
Rostov State Medical University
Russian Federation
Competing Interests:
Russian Federation
Stanislav O. Panenko - MD, PhD-student.
29, Nahichevansky av., 344022 Rostov-on-Don
Competing Interests:
none
References
1. Dedov II, Shestakova MV, Mayorov AYu et al. Standards of specialized diabetes care. Diabetes Mellitus. 2019;22(S1):1-144 (In Russ.). doi: https://doi.org/10.14341/DM221S1
2. Garrison A. Screening, diagnosis, and management of gestational diabetes mellitus. Am Fam Physician. 2015;91(7):460-467.
3. International Diabetes Federation. IDF Diabetes Atlas, 9идеяth edn. Brussels, Belgium: International Diabetes Federation; 2019 [cited May, 2020]. Available from: https://diabetesatlas.org/data/en/indicators/14/
4. Mirghani Dirar A, Doupis J. Gestational diabetes from A to Z. World J Diabetes. 2017;8(12):489-511. doi: https://doi.org/10.4239/wjd.v8.i12.489
5. Shen Y, Jia Y, Zhou J. et al. Association of gestational diabetes mellitus with adverse pregnancy outcomes: our experience and meta-analysis. Int J Diabetes Dev Ctries. 2020;40:357-370. doi: https://doi.org/10.1007/s13410-020-00802-x
6. Fadl HE, Ostlund IK, Magnuson AF, Hanson US. Maternal and neonatal outcomes and time trends of gestational diabetes mellitus in Sweden from 1991 to 2003. Diabet Med. 2010;27(4):436-441. doi: https://doi.org/10.1111/j.1464-5491.2010.02978.x
7. Muche AA, Olayemi OO, Gete YK. Effects of gestational diabetes mellitus on risk of adverse maternal outcomes: a prospective cohort study in Northwest Ethiopia. BMC Pregnancy Childbirth. 2020;20(1):73. doi: https://doi.org/10.1186/s12884-020-2759-8
8. Mitanchez D, Ciangura C, Jacqueminet S. How Can Maternal Lifestyle Interventions Modify the Effects of Gestational Diabetes in the Neonate and the Offspring? A Systematic Review of Meta-Analyses. Nutrients. 2020;12(2):353. doi: https://doi.org/10.3390/nu12020353
9. Poolsup N, Suksomboon N, Amin M. Effect of Treatment of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis. PLoS One. 2014;9(3):e92485. doi: https://doi.org/10.1371/journal.pone.0092485
10. Crowther CA, Hiller JE, Moss JR, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352(24):2477-2486. doi: https://doi.org/10.1056/NEJMoa042973
11. American Diabetes Association. 14. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020;43(S1):S183-S192. doi: https://doi.org/10.2337/dc20-S014
12. Schäfer-Graf UM, Gembruch U, Kainer F, et al. Gestational Diabetes Mellitus (GDM) - Diagnosis, Treatment and Follow-Up. Guideline of the DDG and DGGG (S3 Level, AWMF Registry Number 057/008, February 2018). Geburtshilfe Frauenheilkd. 2018;78(12):1219-1231. doi: https://doi.org/10.1055/a-0659-2596
13. Richtlijn van de Nederlands Vereniging voor Obstetrie en Gynaecologie (NVOG) diabetes mellitus en zwangerschap. Versie 3.0.; 2018 [cited May, 2020]. Available from: https://www.nvog.nl/wp-content/uploads/2018/10/NVOG-richtlijn-Diabetes-mellitus-en-zwangerschap-v3.0-2018.pdf
14. Powe CE, Huston Presley LP, et al. Augmented insulin secretory response in early pregnancy. Diabetologia. 2019;62(8):1445-1452. doi: https://doi.org/10.1007/s00125-019-4881-6.
15. Catalano PM, Tyzbir ED, Roman NM, et al. Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol. 1991;165(6 Pt 1):1667-1672. doi: https://doi.org/10.1016/0002-9378(91)90012-g
16. Kirwan JP, Huston-Presley L, et al. Clinically useful estimates of insulin sensitivity during pregnancy: validation studies in women with normal glucose tolerance and gestational diabetes mellitus. Diabetes Care. 2001;24(9):1602-1607. doi: https://doi.org/10.2337/diacare.24.9.1602
17. Bennewitz HG. De Diabete Mellito, Gravidatatis Symptomate. MD Thesis, University of Berlin; 1824
18. Mestman JH: Historical notes on diabetes in pregnancy. Endocrinologist. 2002;12(3):224-242. doi: https://doi.org/10.1097/00019616-200205000-00010
19. Duncan JM. On puerperal diabetes. Trans Obstet Soc Lond. 1882;24:256
20. Hoet JP, Lukens FD. Carbohydrate metabolism during pregnancy. Diabetes. 1954;3(1):1-12. doi: https://doi.org/10.2337/diab.3.1.1
21. Carrington ER, Shuman CR, Reardon HS. Evaluation of the prediabetic state during pregnancy. Obstet Gynecol. 1957;9(6):664-669. doi: https://doi.org/10.1097/00006250-195706000-00008
22. O’Sullivan JB, Mahan CM. Criteria for the oral glucose tolerance test in pregnancy. Diabetes. 1964;13:278-285.
23. O’Sullivan JB. Establishing criteria for gestational diabetes. Diabetes Care. 1980;3(3):437-439. doi: https://doi.org/10.2337/diacare.3.3.437
24. O’Sullivan JB, Mahan CM, Charles D, et al. Screening criteria for high-risk gestational diabetic patients. Am J Obstet Gynecol. 1973;116(7):895-900. doi: https://doi.org/10.1016/s0002-9378(16)33833-9
25. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982;144(7):768-773. doi: https://doi.org/10.1016/0002-9378(82)90349-0
26. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO Consultation. Part 1: diagnosis and classification of diabetes mellitus. Geneva, Switzerland: World Health Organization; 1999. [cited May, 2020]. Available from: https://apps.who.int/iris/bitstream/handle/10665/66040/WHO_NCD_NCS_99.2.pdf?sequence=1&isAllowed=y
27. Metzger BE, Coustan DR, Trimble ER. Hyperglycemia and Adverse Pregnancy Outcomes. Clin Chem. 2019;65(7):937-938. doi: https://doi.org/10.1373/clinchem.2019.303990
28. Coustan DR, Lowe LP, Metzger BE, Dyer AR. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes. 2009;58(2):453-459. doi: https://doi.org/10.2337/db08-1112
29. Coustan DR, Lowe LP, Metzger BE, Dyer AR. The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: paving the way for new diagnostic criteria for gestational diabetes mellitus. Am J Obstet Gynecol. 2010;202(6):654. doi: https://doi.org/10.1016/j.ajog.2010.04.006
30. Lowe WL Jr, Scholtens DM, Kuang A, et al. Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Gestational Diabetes Mellitus and Childhood Glucose Metabolism. Diabetes Care. 2019;42(3):372-380. doi: https://doi.org/10.2337/dc18-1646
31. Scholtens DM, Kuang A, Lowe LP, et al. Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Glycemia and Childhood Glucose Metabolism. Diabetes Care. 2019;42(3):381-392. doi: https://doi.org/10.2337/dc18-2021
32. Diagnostic Criteria and Classification of Hyperglycaemia First Detected in Pregnancy. Geneva: World Health Organization; 2013.
33. Lee KW, Ching SM, Ramachandran V, et al. Prevalence and risk factors of gestational diabetes mellitus in Asia: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2018;18(1):494. doi: https://doi.org/10.1186/s12884-018-2131-4
34. Miailhe G, Kayem G, Girard G, et al. Selective rather than universal screening for gestational diabetes mellitus? Eur J Obstet Gynecol Reprod Biol. 2015;191:95-100. doi: https://doi.org/10.1016/j.ejogrb.2015.05.003
35. Adam S, Rheeder P. Screening for gestational diabetes mellitus in a South African population: Prevalence, comparison of diagnostic criteria and the role of risk factors. S Afr Med J. 2017;107(6):523-527. doi: https://doi.org/10.7196/SAMJ.2017.v107i6.12043
36. Jiménez-Moleón JJ, Bueno-Cavanillas A, Luna-del-Castillo JD, et al. Predictive value of a screen for gestational diabetes mellitus: influence of associated risk factors. Acta Obstetricia et Gynecologica Scandinavica. 2000;79(11):991-998. doi: https://doi.org/10.1080/00016340009169248
37. Alberico S, Strazzanti C, De Santo D, et al. Gestational diabetes: universal or selective screening? J Matern Fetal Neonatal Med. 2004;16(6):331-337. doi: https://doi.org/10.1080/14767050400018114
38. Baliutaviciene D, Petrenko V, Zalinkevicius R. Selective or universal diagnostic testing for gestational diabetes mellitus. Int J Gynaecol Obstet. 2002;78(3):207-211. doi: https://doi.org/10.1016/s0020-7292(02)00149-2.
39. Benhalima K, Van Crombrugge P, Moyson C, et al. Risk factor screening for gestational diabetes mellitus based on the 2013 WHO criteria. Eur J Endocrinol. 2019;180(6):353-363. doi: https://doi.org/10.1530/EJE-19-0117
40. Griffin ME, Coffey M, Johnson H, et al. Universal vs. risk factor-based screening for gestational diabetes mellitus: detection rates, gestation at diagnosis and outcome. Diabet Med. 2000;17(1):26-32. doi: https://doi.org/10.1046/j.1464-5491.2000.00214.x
41. Farrar D, Fairley L, Wright J, et al. Evaluation of the impact of universal testing for gestational diabetes mellitus on maternal and neonatal health outcomes: a retrospective analysis. BMC Pregnancy Childbirth. 2014;14:317. doi: https://doi.org/10.1186/1471-2393-14-317
42. Cosson E, Vicaut E, Sandre-Banon D, et al. Performance of a selective screening strategy for diagnosis of hyperglycaemia in pregnancy as defined by IADPSG/WHO criteria. Diabetes Metab. 2020;46(4):311-318. doi: https://doi.org/10.1016/j.diabet.2019.09.002
43. Farrar Di, Simmonds M, Bryant M, et al. Risk factor screening to identify women requiring oral glucose tolerance testing to diagnose gestational diabetes: A systematic review and meta-analysis and analysis of two pregnancy cohorts. PLoS One. 2017;12(4):e0175288. doi: https://doi.org/10.1371/journal.pone.0175288
44. Ogonowski J, Miazgowski T, Homa K, et al. Low predictive value of traditional risk factors in identifying women at risk for gestational diabetes. Acta Obstet Gynecol Scand. 2007;86(10):1165-1170. doi: https://doi.org/10.1080/00016340701505044
45. Helseth R, Salvesen O, Stafne SN, et al. Gestational diabetes mellitus among Nordic Caucasian women: prevalence and risk factors according to WHO and simplified IADPSG criteria. Scand J Clin Lab Invest. 2014;74(7):620-628. doi: https://doi.org/10.3109/00365513.2014.928942.
46. Muniswaran G, Soelar SA, Karalasingam SD, et al. Effectiveness of selective risk based screening for Gestational Diabetes (GDM) in Malaysia: A retrospective cohort study based on the National Obstetric Registry (NOR) of Malaysia. Med J Malaysia. 2017;72(1):46-49.
47. Sert UY, Ozgu-Erdinc AS. Gestational Diabetes Mellitus Screening and Diagnosis. In: Advances in Experimental Medicine and Biology. 2020;10:231-255. doi: https://doi.org/10.1007/5584_2020_512
48. Donovan L, Hartling L, Muise M, et al. Screening tests for gestational diabetes: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2013;159(2):115-122. doi: https://doi.org/10.7326/0003-4819-159-2-201307160-00657
49. Benhalima K, Van Crombrugge P, Moyson C, et al. The Sensitivity and Specificity of the Glucose Challenge Test in a Universal Two-Step Screening Strategy for Gestational Diabetes Mellitus Using the 2013 World Health Organization Criteria. Diabetes Care. 2018;41(7):e111-e112. doi: https://doi.org/10.2337/dc18-0556
50. Benhalima K, Van Crombrugge P, Moyson C, et al. A Modified Two-Step Screening Strategy for Gestational Diabetes Mellitus Based on the 2013 WHO Criteria by Combining the Glucose Challenge Test and Clinical Risk Factors. J Clin Med. 2018;7(10):351. doi: https://doi.org/10.3390/jcm7100351
51. Olagbuji BN, Aderoba AK, Kayode OO, et al. Accuracy of 50-g glucose challenge test to detect International Association of Diabetes and Pregnancy Study Groups criteria-defined hyperglycemia. Int J Gynaecol Obstet. 2017;139(3):312-317. doi: https://doi.org/10.1002/ijgo.12304
52. Van Leeuwen M, Zweers EJ, Opmeer BC, et al. Comparison of accuracy measures of two screening tests for gestational diabetes mellitus. Diabetes Care. 2007;30(11):2779-2784. doi: https://doi.org/10.2337/dc07-0571
53. Dwarakanath L, Hema KR, Hemashree P. One step procedure for screening and diagnosis of gestational diabetes mellitus by diabetes in pregnancy study group of India. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 2019;8(8):3344-3349. doi: https://doi.org/10.18203/2320-1770.ijrcog20193563
54. Chevalier N, Fénichel P, Giaume V, et al. Universal two-step screening strategy for gestational diabetes has weak relevance in French Mediterranean women: should we simplify the screening strategy for gestational diabetes in France? Diabetes Metab. 2011;37(5):419-425. doi: https://doi.org/10.1016/j.diabet.2011.01.004
55. Wu ET, Nien FJ, Kuo CH, et al. Diagnosis of more gestational diabetes lead to better pregnancy outcomes: Comparing the International Association of the Diabetes and Pregnancy Study Group criteria, and the Carpenter and Coustan criteria. J Diabetes Investig. 2016;7(1):121-126. doi: https://doi.org/10.1111/jdi.12378
56. Roeckner JT, Sanchez-Ramos L, Jijon-Knupp R, Kaunitz AM. Single abnormal value on 3-hour oral glucose tolerance test during pregnancy is associated with adverse maternal and neonatal outcomes: a systematic review and metaanalysis. Am J Obstet Gynecol. 2016;215(3):287-297. doi: https://doi.org/10.1016/j.ajog.2016.04.040
57. Feldman RK, Tieu RS, Yasumura L. Gestational Diabetes Screening: The International Association of the Diabetes and Pregnancy Study Groups Compared With Carpenter-Coustan Screening. Obstet Gynecol. 2016;127(1):10-17. doi: https://doi.org/10.1097/AOG.0000000000001132
58. Wu ET, Nien FJ, Kuo CH, et al. Diagnosis of more gestational diabetes lead to better pregnancy outcomes: Comparing the International Association of the Diabetes and Pregnancy Study Group criteria, and the Carpenter and Coustan criteria. J Diabetes Investig. 2016;7(1):121-126. doi: https://doi.org/10.1111/jdi.12378
59. Kim MH, Kwak SH, Kim SH, et al. Pregnancy Outcomes of Women Additionally Diagnosed as Gestational Diabetes by the International Association of the Diabetes and Pregnancy Study Groups Criteria. Diabetes Metab J. 2019;43(6):766-775. doi: https://doi.org/10.4093/dmj.2018.0192
60. Sevket O, Ates S, Uysal O, et al. To evaluate the prevalence and clinical outcomes using a one-step method versus a two-step method to screen gestational diabetes mellitus. J Matern Fetal Neonatal Med. 2014;27(1):36-41. doi: https://doi.org/10.3109/14767058.2013.799656
61. Ogunleye OK, Davidson KD, Gregg AR, Egerman RS. Perinatal outcomes after adopting 1- versus 2-step approach to diagnosing gestational diabetes. J Matern Fetal Neonatal Med. 2017;30(2):186-190. doi: https://doi.org/10.3109/14767058.2016.1166201
62. Oriot P, Selvais P, Radikov J, et al. Assessing the incidence of gestational diabetes and neonatal outcomes using the IADPSG guidelines in comparison with the Carpenter and Coustan criteria in a Belgian general hospital. Acta Clin Belg. 2014;69(1):8-11. doi: https://doi.org/10.1179/0001551213Z.0000000004
63. Costa E, Kirckpartick C, Gerday C, et al. Change in prevalence of gestational diabetes and obstetric complications when applying IADPSG screening criteria in a Belgian French speaking University Hospital. A retrospective cohort study. BMC Pregnancy Childbirth. 2019;19(1):249. doi: https://doi.org/10.1186/s12884-019-2406-4
64. Huhn EA, Massaro N, Streckeisen S, et al. Fourfold increase in prevalence of gestational diabetes mellitus after adoption of the new International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria. J Perinat Med. 2017;45(3):359-366. doi: https://doi.org/10.1515/jpm-2016-0099
65. Lucovnik M, Steblovnik L, Verdenik I, et al. Changes in perinatal outcomes after implementation of IADPSG criteria for screening and diagnosis of gestational diabetes mellitus: A national survey. Int J Gynaecol Obstet. 2020;149(1):88-92. doi: https://doi.org/10.1002/ijgo.13098
66. Duran A, Sáenz S, Torrejón MJ, et al. Introduction of IADPSG criteria for the screening and diagnosis of gestational diabetes mellitus results in improved pregnancy outcomes at a lower cost in a large cohort of pregnant women: the St. Carlos Gestational Diabetes Study. Diabetes Care. 2014;37(9):2442-2450. doi: https://doi.org/10.2337/dc14-0179
67. Hung TH, Hsieh TT. The effects of implementing the International Association of Diabetes and Pregnancy Study Groups criteria for diagnosing gestational diabetes on maternal and neonatal outcomes. PLoS One. 2015;10(3):e0122261. doi: https://doi.org/10.1371/journal.pone.0122261
68. Hosseini E, Janghorbani M. Systematic review and meta-analysis of diagnosing gestational diabetes mellitus with one-step or two-step approaches and associations with adverse pregnancy outcomes. Int J Gynaecol Obstet. 2018;143(2):137-144. doi: https://doi.org/10.1002/ijgo.12644
69. Saccone G, Khalifeh A, Al-Kouatly HB, et al. Screening for gestational diabetes mellitus: one step versus two step approach. A meta-analysis of randomized trials. J Matern Fetal Neonatal Med. 2020;33(9):1616-1624. doi: https://doi.org/10.1080/14767058.2018.1519543
70. Saccone G, Caissutti C, Khalifeh A, et al. One step versus two step approach for gestational diabetes screening: systematic review and meta-analysis of the randomized trials. J Matern Fetal Neonatal Med. 2019;32(9):1547-1555. doi: https://doi.org/10.1080/14767058.2017.1408068
71. Li Z, Cheng Y, Wang D, et al. Incidence Rate of Type 2 Diabetes Mellitus after Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis of 170,139 Women. J Diabetes Res. 2020;2020:1-12. doi: https://doi.org/10.1155/2020/3076463
72. Pan L, Leng J, Liu G, et al. Pregnancy outcomes of Chinese women with gestational diabetes mellitus defined by the IADPSG’s but not by the 1999 WHO’s criteria. Clin Endocrinol (Oxf). 2015;83(5):684-693. doi: https://doi.org/10.1111/cen.12801
73. Goedegebure EAR, Koning SH, Hoogenberg K, et al. Pregnancy outcomes in women with gestational diabetes mellitus diagnosed according to the WHO-2013 and WHO-1999 diagnostic criteria: a multicentre retrospective cohort study. BMC Pregnancy Childbirth. 2018;18(1):152. doi: https://doi.org/10.1186/s12884-018-1810-5
74. Shareef M, Saleh L, van den Meiracker AH, Visser W. The impact of implementing the WHO-2013 criteria for gestational diabetes mellitus on its prevalence and pregnancy outcomes: A comparison of the WHO-1999 and WHO-2013 diagnostic thresholds. Eur J Obstet Gynecol Reprod Biol. 2020;246:14-18. doi: https://doi.org/10.1016/j.ejogrb.2019.12.013
75. de Wit L, Zijlmans AB, Rademaker D, et al. Estimated impact of introduction of new diagnostic criteria for gestational diabetes mellitus. World J Diabetes. 2021;12(6):868-882. doi: https://doi.org/10.4239/wjd.v12.i6.868
76. Chi C, Loy SL, Chan SY, et al. Impact of adopting the 2013 World Health Organization criteria for diagnosis of gestational diabetes in a multi-ethnic Asian cohort: a prospective study. BMC Pregnancy Childbirth. 2018;18(1):69. doi: https://doi.org/10.1186/s12884-018-1707-3
77. Basri NI, Mahdy ZA, Ahmad S, et al. The World Health Organization (WHO) versus The International Association of Diabetes and Pregnancy Study Group (IADPSG) diagnostic criteria of gestational diabetes mellitus (GDM) and their associated maternal and neonatal outcomes. Horm Mol Biol Clin Investig. 2018;34(1). doi: https://doi.org/10.1515/hmbci-2017-0077
78. Mo X, Gai Tobe R, Takahashi Y, et al. Economic Evaluations of Gestational Diabetes Mellitus Screening: A Systematic Review. J Epidemiol. 2021;31(3):220-230. doi: https://doi.org/10.2188/jea.JE20190338
Supplementary files
Review
For citations:
Volkova N.I., Panenko S.O. Gestational diabetes mellitus: current screening problems. Diabetes mellitus. 2022;25(1):72-80. (In Russ.) https://doi.org/10.14341/DM12727
Views:
10063
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
